Determination of Morphine in Human Urine by the Novel Competitive Fluorescence Immunoassay

Abstract EN

A competitive fluorescence immunoassay for the identification and quantification of morphine has been developed on the basis of hapten-coated plate format.

Hapten was prepared through covalent conjugating a morphine derivative with albumin bovine.

In the immunoassay, the hapten was inoculated on a 96-well plate and then bound with monoclonal antibodies labeled with a signal indicating dye, fluorescein isothiocyanate (FITC).

Unbound FITC-antibodies were rinsed off from the plate.

The fluorescein intensity decreases in the presence of morphine molecules due to the competitively binding to antibodies against hapten.

The intensity is inversely correlated with the concentration of morphine.

In quantitative analysis for urine samples, we obtained a linearity range of 0.2 μg/mL∼2.5 μg/mL, along with a detection limit of c.a.

1 ng/mL.

The fluorescence immunoassay shows low cross-reactivity (below 10%) to 6-acetylmorphine, 3-acetylmorphine, and heroine.

The developed method produced comparable results to the standard GC-MS/MS method.

In conclusion, a rapid and efficient screening tool for morphine in clinical human urine has been established.